Kawa Capital Management, Inc - EUROPEAN BIOTECH ACQUTN CORP ownership

Back to all holdings Add to watchlist

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 51 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Kawa Capital Management, Inc ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q2 2022$264,000
+0.4%
27,0000.0%1.23%
+181.3%
Q1 2022$263,000
+0.4%
27,0000.0%0.44%
+73.8%
Q4 2021$262,000–27,000–0.25%–
 Download
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders